ORIGINAL ARTICLE Year : 2023  |  Volume : 13  |  Issue : 4  |  Page : 148-155

Cardioprotective effects of Pinus eldarica bark extract on adrenaline-induced myocardial infarction in rats

Leila Safaeian1, Zahra Haghighatian2, Behzad Zolfaghari3, Mahdi Amindeldar1
1 Department of Pharmacology and Toxicology, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Pathology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
3 Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Date of Submission14-Mar-2023Date of Decision31-Mar-2023Date of Acceptance03-Apr-2023Date of Web Publication25-Apr-2023

Correspondence Address:
Leila Safaeian
Department of Pharmacology and Toxicology, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan
Iran

Source of Support: This study was financially supported by Vice-Chancellery for Research and Technology of Isfahan University of Medical Sciences (research projects No. 3400680), Conflict of Interest: None

DOI: 10.4103/2221-1691.374231

Objective: To investigate the effect of Pinus eldarica bark extract on adrenaline-induced myocardial infarction.
Methods: Hydroalcoholic extract was prepared using maceration method and its total phenolic content was determined using the Folin-ciocalteu method. Pretreatment was done by oral administration of 100, 200, and 400 mg/kg Pinus eldarica bark extract for 16 days in male Wistar rats. Injection of adrenaline (2 mg/kg, s.c.) was performed on the 15th and 16th days for induction of myocardial infarction. Lead II EEG was recorded. Serum cardiac marker enzymes and antioxidative parameters were evaluated and a histopathological examination of heart tissues was performed.
Results: Pretreatment with Pinus eldarica bark extract especially at its high doses significantly lowered the ST-segment elevation, improved heart rate, and decreased RR interval in ECG pattern of rats with adrenaline-induced myocardial infarction. It declined serum markers of heart damage including aspartate aminotransferase, lactate dehydrogenase, and creatine phosphokinase-MB, and also decreased lipid peroxidation marker, and heart weight while raising total antioxidant capacity and considerably improved histopathological alterations of the heart induced by adrenaline.
Conclusions: Pinus eldarica bark extract shows beneficial cardioprotective and antioxidant effects against adrenaline-induced myocardial infarction. It can be further explored as a potential treatment for myocardial infarction.

Keywords: Adrenaline; Antioxidant; Lipid peroxidation; Myocardial infarction; Pinus eldarica

How to cite this article:
Safaeian L, Haghighatian Z, Zolfaghari B, Amindeldar M. Cardioprotective effects of Pinus eldarica bark extract on adrenaline-induced myocardial infarction in rats. Asian Pac J Trop Biomed 2023;13:148-55
How to cite this URL:
Safaeian L, Haghighatian Z, Zolfaghari B, Amindeldar M. Cardioprotective effects of Pinus eldarica bark extract on adrenaline-induced myocardial infarction in rats. Asian Pac J Trop Biomed [serial online] 2023 [cited 2023 Apr 27];13:148-55. Available from: https://www.apjtb.org/text.asp?2023/13/4/148/374231

Significance:
Pines belonging to the Pinus genus have shown beneficial cardiovascular effects. This study demonstrates the cardioprotective effects of Pinus eldarica bark extract against adrenaline-induced myocardial infarction through reducing the enzyme markers of heart damage and lipid peroxidation and improving electrocardiogram, heart histopathology and antioxidant defense.

  1. Introduction 

Cardiovascular diseases (CVD) are the most important reason for death in the world. According to global statistics, around 17.9 million people die worldwide every year due to cardiovascular problems, which includes 32% of all deaths. Heart attack and stroke are responsible for 85% of this mortality[1]. Heart attack or myocardial infarction (MI) is a critical medical emergency that may lead to heart failure or death if not quickly and properly managed. Current treatment approaches such as drugs and surgery are not able to completely restore the structure and function of the ischemic heart. Cardioprotective interventions that prevent heart attack or at least reduce myocardial tissue damage and improve heart adaptation in post-MI conditions are of great importance and concern[2],[3].

Oxidative stress, mitochondrial dysfunction, inflammatory process, increased intracellular calcium, necrosis, and apoptosis have been proposed in the pathogenesis of cardiovascular damage during MI[4]. Oxidative stress through excess production of reactive oxygen species and lipid peroxidation in the cell membrane is involved in the permanent injury to the myocardial membrane and loss of cardiac function[5]. Many investigations have shown the promising role of natural polyphenolic compounds in CVD[6]. Pines belonging to the Pinus genus are rich in polyphenols and proanthocyanidins with beneficial cardiovascular effects[7],[8]. Pinus eldarica (P. eldarica) Medw., one of the fast-growing pines from Pinaceae family is native to the Middle East and broadly grows in Iran[9]. The bark extract of P. eldarica has high polyphenolic content with antioxidant and cytoprotective effects against oxidative damage in human endothelial cells, and capability to improve hyperlipidemia, atherosclerosis, diabetes, and inflammatory conditions[10],[12],[13]. The current study aimed to examine the possible helpful effects of the bark extract of P. eldarica on adrenaline-induced MI in rats.

  2. Materials and methods 

2.1. Plant material and preparation of extract

The barks of P. eldarica were collected from pine stands in November 2021 at Isfahan city (Isfahan Province) in the center of Iran. The pine sample was authenticated with a voucher specimen (No. 3318) stored in the Herbarium at the Department of Pharmacognosy.

The hydroalcoholic extract was prepared by maceration technique. Briefly, the dried pine materials were ground and macerated with ethanol (70%) at room temperature for 72 h three times. After filtration, the resultant extract was concentrated by removing the solvent using a vacuum rotary evaporator under low pressure. The extract powder was acquired through freeze-drying and reserved at –20 °C. Different doses of hydroalcoholic extract of pine bark were dissolved in normal saline and administered orally using an intragastric tube.

2.2. Determination of total phenolic content

In our previous phytochemical analysis through high pressure liquid chromatography, polyphenolic compounds including catechin (3.41%), ferulic acid (2.27%), taxifolin (1.95%) and caffeic acid (1.62%) were found in the bark extract of P. eldarica[9]. In this study, Folin-Ciocalteu assay was done for determining the amount of total phenolic compounds and standardization of the hydroalcoholic extract of P. eldarica bark based on the content of phenolics. A mixture of phosphomolybdate and phosphotungstate solution was used as the Folin-Ciocalteu reagent in this colorimetric method. Briefly, the pine or standard samples were mixed with sodium carbonate (20%) and then incubated with diluted Folin-Ciocalteu reagent for 120 min. The UV absorbance was detected using a spectrophotometer at 765 nm. The total phenolic content of samples was assessed using a standard curve depicted by different concentrations of gallic acid and specified in terms of mg of gallic acid equivalent (GAE)/g of the dried pine bark extract[14].

2.3. Animals and experimental design

Male adult Wistar rats, weighing (250 ± 20) g, were acquired from the animal house of the School of Pharmacy and Pharmaceutical Sciences. The rats were maintained under room temperature of 20-25 °C and a 12 h light/12 h dark cycle with free access to water and standard food. Animals were adapted under experimental environment for 1 week before the beginning of the experiment. The experimental practice was done in accordance with the international guidelines for laboratory animal use and care.

The adrenaline-induced MI model was developed by administration of adrenaline (Iran Hormone Pharmaceutical Co., Tehran, Iran) 2 mg/kg subcutaneously (s.c.) for 2 consecutive days (24 h apart)[15]. Rats were randomly divided into 6 groups with 6 rats in each group as follows: The first group as the normal control received oral administration of the vehicle (normal saline) for 16 d and s.c. injection of normal saline on days 15 and 16. The second group as the extract control received only P. eldarica bark extract orally at the dose of 400 mg/kg for 16 d. In the third group as the MI control group, adrenaline (2 mg/kg/day, s.c.) was administered on days 15 and 16. In groups 4-6 as the test groups, rats were treated with 100, 200, or 400 mg/kg of P. eldarica bark extract orally for 16 d and received s.c. injection of adrenaline on days 15 and 16. The doses of P. eldarica bark extract were selected based on the previous studies[11],[13].

Animals were weighed at the start of the experiment and then every other day. After 24 h of adrenaline administration, rats were anesthetized and lead II electrocardiograph (ECG) was recorded using computerized data acquisition eWave system and analyzed with eProbe software (Science Beam; Parto Danesh Co., Iran). Heart rate (HR) and RR interval were recorded and alteration of ST-segment was evaluated. Then, blood samples were taken by retro-orbital technique from the anesthetized rats and serum was separated for evaluation of biochemical parameters of heart damage and oxidative stress. After scarifice under CO2 exposure, hearts were removed, weighed, and then fixed in 10% formalin solution and used for histopathological examination after additional processing.

2.4. Biochemical assay

Serum levels of creatine phosphokinase-MB (CK-MB), lactate dehydrogenase (LDH), and aspartate aminotransferase (AST) were estimated spectrophotometrically at 340 nm using the commercial biochemical kits (Pars Azmoon Co., Iran)[16].

2.5. Lipid peroxidation assay

The level of serum malondialdehyde (MDA) was examined carefully for assessment of lipid peroxidation via spectrophotometrically thiobarbituric acid reactive substances test using a standard kit (Hakiman Shargh Research Co., Isfahan, Iran). The absorbance of samples was measured at 532 nm and the content of lipid peroxides was expressed as MDA equivalents in μM[17].

2.6. Total antioxidant capacity assay

The ferric reducing antioxidant power (FRAP) test was used for evaluation of the antioxidant power in serum samples using a standard kit (Hakiman Shargh Research Co., Isfahan, Iran). This spectrophotometrical assay estimates the reduction of ferric-tripyridyl triazine complex to ferrous form at 570 nm. The FRAP levels were expressed as mM of ferrous sulphate equivalents using a standard curve of ferrous sulphate[18].

2.7. Histopathological examination

The heart samples were processed and embedded in paraffin blocks. Sections of 5 µm thickness were stained with hematoxylin and eosin (H&E) and inspected under a light microscope for histopathological alterations. Finally, tissue images of heart sections were obtained using a digital camera.

2.8. Statistical analysis

Data were expressed as mean ± standard error of mean (SEM) and subjected to one-way analysis of variance (ANOVA) and then Tukey post-hoc test via the Statistical Package for Social Sciences (SPSS software version 25.0) for statistical evaluation. The significant difference was set at P value<0.05.

2.9. Ethical statement

The research procedures were approved by the Institutional Research Ethics Committee of Isfahan University of Medical Sciences with ethics approval ID: IR.MUI.RESEARCH.REC.1400.353.

  3. Results 

3.1. Total phenolic content

Total phenolic content of P. eldarica bark extract was determined as (560.65 ± 44.00) mg GAE/g of the dried plant extract.

3.2. Effect of P. eldarica bark extract on ECG parameters

As shown in [Figure 1], administration of adrenaline (2 mg/kg) for 2 successive days caused obvious changes in ECG pattern such as elevation of ST segment. Moreover, an increase in RR interval by 36.42% and a decrease in HR by 26.82% were observed in rats receiving adrenaline compared with the control group (P<0.001) [Table 1].

Figure 1: Representative electrocardiographs traces of lead II for normal rats (A); rats treated with Pinus eldarica (P. eldarica) bark extract (B); rats with adrenaline-induced myocardial infarction (C); rats with adrenaline-induced myocardial infarction treated with P. eldarica bark extract at doses of 100 (D), 200 (E), and 400 mg/kg (F).

Click here to view

Table 1: Effect of hydroalcoholic extract of P. eldarica bark on electrocardiogram parameters in rats with adrenaline-induced myocardial infarction (MI).

Click here to view

Pretreatment with P. eldarica bark extract at the doses of 200 and 400 mg/kg significantly lowered the ST-segment elevation and improved the HR (P<0.05 and P<0.001 at 200 and 400 mg/kg, respectively) in rats with adrenaline-induced MI. P. eldarica extract also notably decreased RR interval at a dose of 400 mg/kg (P<0.01) [Figure 1] and [Table 1].

3.3. Effect of P. eldarica bark extract on biochemical parameters

[Figure 2] indicates the effect of hydroalcoholic extract of P. eldarica bark on biochemical parameters in adrenaline-induced MI. Following adrenaline injection, the serum level of CK-MB activity was increased to (319.20 ± 38.00) IU/L compared to the normal control group (156.00 ± 0.27) IU/L (P<0.05). Pretreatment with different doses of P. eldarica extract declined the activity of this enzyme, especially at a dose of 400 mg/kg of extract (147.20±24.00) IU/L when compared to the MI control group (P<0.05). A significant elevation in the activity of LDH was observed after administration of adrenaline (P<0.001), which was reduced by treatment with P. eldarica bark extract. Adrenaline also caused a significant rise in the serum activity of AST (P<0.001). P. eldarica extract (200 and 400 mg/kg) significantly reduced AST level as compared to MI control rats (P<0.001). Treatment with 400 mg/kg of P. eldarica extract alone in normal rats did not change the levels of biochemical parameters.

Figure 2: Effect of P. eldarica bark extract (100-400 mg/kg) on serum CK-MB (A), LDH (B), and AST (C) in rats with adrenaline-induced MI. Values are expressed as mean ± SEM (n=6) and analyzed by one-way ANOVA, followed by Tukey post hoc analysis. #P<0.05 and ###P<0.001 versus the normal control; *P<0.05, **P<0.01 and ***P<0.001 versus the MI control. CK-MB: creatine phosphokinase-MB, LDH: lactate dehydrogenase, AST: aspartate aminotransferase.

Click here to view

3.4. Effect of P. eldarica bark extract on lipid peroxidation and total antioxidant capacity

As shown in [Figure 3], adrenaline resulted in a high increase in the content of MDA when compared to the normal control group (P<0.001). Treatment with P. eldarica bark extract at the doses of 100, 200, and 400 mg/kg markedly attenuated the MDA level (P<0.05, P<0.01, and P<0.001, respectively).

Figure 3: Effect of P. eldarica bark extract (100-400 mg/kg) on serum MDA level (A) and FRAP value (B) in rats with adrenaline-induced MI. #P<0.05 and ###P<0.001 versus the normal control; *P<0.05, **P<0.01 and ***P<0.001 versus the MI control. MDA: malondialdehyde, FRAP: ferric reducing antioxidant power.

Click here to view

The FRAP value was notably reduced in serum of adrenaline-treated rats (P<0.05). P. eldarica bark extract significantly raised the FRAP value at a dose of 400 mg/kg compared to the MI control rats (P<0.05) [Figure 3].

3.5. Effect of P. eldarica bark extract on body and heart weight changes

As seen in [Table 2], the weight of all rats was increased during the test period and no significant difference in the body weight changes was observed between different groups. The adrenaline-induced MI resulted in a significant rise in heart weight (P<0.001). However, P. eldarica bark extract markedly lowered heart weight at doses of 200 and 400 mg/kg (P<0.001).

Table 2: Effect of hydroalcoholic extract of P. eldarica bark on body weight and relative heart weight of rats with adrenaline-induced MI (%).

Click here to view

3.6. Effect of P. eldarica bark extract on heart histopathology

In morphological examination of the heart section, a normal structure of cardiomyocytes without any inflammation was observed in the heart of control rats [Figure 4]A and rats treated only with P. eldarica bark extract (400 mg/kg) [Figure 4]B. Conversely, clear histological changes including infiltration of inflammatory cells, degeneration of myocytes (rupture and vacuolization), as well as areas of hemorrhage and congestion of blood vessels were demonstrated after injection of 2 mg/kg adrenaline for 2 successive days in MI control rats [Figure 4]C. Administration of P. eldarica bark extract at the dose of 100 mg/kg had no significant effect [Figure 4]D, however, 200 mg/kg [Figure 4]E and 400 mg/kg [Figure 4]F improved histopathological alterations of the heart induced by adrenaline.

Figure 4: Representative H & E sections of heart tissue for normal control (A); P. eldarica bark extract alone treated group (B); adrenaline-induced MI (C); P. eldarica-treated MI rats at 100 (D), 200 (E) and 400 mg/kg (F); ×400 magnification. Arrows indicate hemorrhage and congestion (red), inflammation (yellow) and degeneration of myocytes (blue).

Click here to view

  4. Discussion 

The current study examined the effects of P. eldarica bark extract pretreatment on parameters of cardiac damage in a MI rat model. The adrenaline-induced MI was confirmed by irregularities in ECG pattern including elevated ST segment, prolonged RR interval and declined HR, raised serum levels of CK-MB, LDH, and AST, cardiac weight gaining, histopathological alterations, and oxidative damage. MI induced by catecholamines including adrenaline and isoproterenol in mice and rats is used as a standard model to evaluate the potential of compounds with possible cardioprotective activities[17],[19]. ECG abnormalities especially ST-segment elevation occur due to the difference between the ischemic and non-ischemic area indicating cell membrane dysfunction such as ischemia, cardiac necrosis, and myocardial damage[5],[20]. Adrenaline, as a beta-adrenergic receptor agonist, causes myocardial hyperactivity and results in coronary artery spasm, and leads to heart ischemia by affecting alpha-adrenergic receptors. Following ischemia and infarction caused by necrosis and myocyte damage, mean arterial pressure, HR, and heart contractility are reduced[21].

Myocardial injury caused by adrenaline administration also leads to leakage of cardiac enzymes including CK-MB, LDH, and AST into the bloodstream[17]. The release of these diagnostic enzymes occurs due to the catecholamine-induced oxidative stress and overstimulation of beta-adrenergic receptors and subsequently functional and structural damages in the myocardium which lead to the disruption in the permeability and plasma membrane integrity[16].

In this study, pretreatment with hydroalcoholic extract of P. eldarica bark at the doses of 200 and 400 mg/kg showed protective effect against adrenaline-induced MI in rats through improving ECG pattern, reducing serum levels of CK-MB, LDH, and AST, and alleviating cardiac weight gaining and pathological changes. There was a reduction of 17.9% in RR interval and an increase of 22.2% in HR after administration of P. eldarica bark extract at a dose of 400 mg/kg in rats.

Beneficial cardiovascular effects have been observed in other Pinus species. Pinus pinaster bark extract (pycnogenol) regulates many risk factors of CVD such as high blood pressure, hemoglobin A1C, platelet aggregation, and hyperlipidemia[22]. Pycnogenol has also improved endothelium function in patients with coronary artery problems by reducing oxidative stress, increasing nitric oxide levels, and improving blood supply[23]. Pinus radiata bark extract (Enzogenol) has useful effects in improving brain, heart, and vascular function, and preventing arteriosclerosis development[24],[25]. Sudjarwo and co-workers also reported cardioprotective effects of Pinus merkusii bark extract (100-400 mg/kg) against heart damage caused by lead acetate through modifying LDH, CK-MB, and histological alterations in rats[26]. Moreover, the anti-thrombotic activity and prevention of collagen-dependent platelet aggregation have been proved for Pinus gerardiana nut oil in vitro[27]. Regarding P. eldarica, antidyslipidemic activity has been reported for 200 and 400 mg/kg of bark extract through reversing hyperglycemia, hypertriglyceridemia, and hypercholesterolemia[11]. In the study of Huseini et al., P. eldarica nut extract (100 and 200 mg/kg) reduced blood cholesterol levels and improved aortic atherosclerotic involvement in hypercholesterolemic rabbits[12]. Moreover, P. eldarica bark extract has shown cell protective effects against oxidative damage in human endothelial cells in vitro[10].

Our results also showed the antioxidant activities of P. eldarica bark extract by improving total antioxidant capacity and declining lipid peroxidation in adrenaline-induced MI. High amounts of phenolic compounds in the bark of P. eldarica [(560.65 ± 44.00) mg GAE/g of extract] denote its possible beneficial effects in many disorders related to oxidative stress. Varied quantities have been reported for total phenolic content in different species of Pinus. In the study of Kim and his colleagues, total phenolics in the aqueous extract of Pinus thunbergii, Pinus densiflora, and Pinus pinaster were calculated as (192.9 ± 13.4), (524.70 ± 2.76) and (440.00 ± 2.23) mg GAE/g of extract, respectively[28]. The amounts of phenolic compounds in the plants and their antioxidant properties may be affected by the place of growth, harvesting time, techniques, and different solvents used for extraction[29]. In general, the total phenolic content in the bark of pine tree is much higher than its seeds and needle[30].

The existence of bioactive components in the bark of P. eldarica including polyphenolics such as taxifolin, catechin, ferulic acid, and caffeic acid, and terpenoids such as β-caryophyllene and α-pinene is accountable for the cardiovascular activities of this pine[9]. There is much evidence for antioxidant, vasorelaxant, and antihyperlipidemic effects of taxifolin[31]. Recent studies have reported the protective activities of taxifolin against cardiac injuries caused by isoproterenol or ischemia/reperfusion through diminishing inflammatory, oxidative, and apoptotic pathways and stimulating Nrf2 (nuclear factor erythroid 2-related factor 2)/HO-1 (heme oxygenase-1) signal[32],[33]. Catechins also possess many beneficial impacts on cardiovascular system by counteracting hypertension, atherosclerosis, and thromboembolic events[34]. Moreover, phenolic acids have shown potent protection against various CVD risk factors[35]. In the study of Yogeeta et al., ferulic acid accompanied by ascorbic acid inhibited lipid peroxidation, restored antioxidant defense, and enzymatic myocardial indicator levels during MI induced by isoproterenol[36].

The major limitations of the present study included the requirement for high doses of catecholamine for induction of MI model which may be associated with other side effects and also lack of exploration of the detailed molecular mechanisms involved in the cardioprotective effect of P. eldarica bark extract.

In conclusion, the present findings confirmed that the hydroalcoholic extract of P. eldarica bark protected against adrenaline-induced MI in rats by improving ECG patterns, reducing serum levels of cardiac enzymes, attenuating pathological changes and lipid peroxidation, and improving total antioxidant capacity. Thus, P. eldarica bark can be explored as a potential cardioprotective treatment against MI, which needs further investigation.

Conflict of interest statement

The authors have no conflict of interest to declare.

Funding

This study was financially supported by Vice-Chancellery for Research and Technology of Isfahan University of Medical Sciences (research projects No. 3400680).

Authors’ contributions

LS was responsible for the conceptualization of the study, supervision, designing the animal investigation, and editing of the manuscript; ZH contributed to the histopathological examination; BZ designed the herbal studies; MA was involved in the animal treatments, data acquisition, and preparation of the manuscript.

 

  References 
1.Al-Gahtani S, Abozaid T, Al-Gahtani S, Shoukri MM, Aleid M. Investigating trend in cardiovascular disease mortality and its association with obesity in the Gulf Cooperative Council (GCC) countries from 1990 to 2019. Open J Epidemiol 2022; 12(3): 221-230.  
    2.Gabriel-Costa D. The pathophysiology of myocardial infarction-induced heart failure. Pathophysiology 2018; 25(4): 277-284.  
    3.Perricone AJ, Vander Heide RS. Novel therapeutic strategies for ischemic heart disease. Pharmacol Res 2014; 89: 36-45.  
    4.Xiang M, Lu Y, Xin L, Gao J, Shang C, Jiang Z, et al. Role of oxidative stress in reperfusion following myocardial ischemia and its treatments. Oxid Med Cell Longev 2021; 2021: 6614009.  
    5.Toutounchi NS, Afrooziyan A, Rameshrad M, Rezabakhsh A, Vaez H, Hamedeyazdan S, et al. Cardioprotective effects of rosmarinic acid on isoproterenol-induced myocardial infarction in rats. Pharm Sci 2017; 23(2): 103-111.  
    6.Alotaibi BS, Ijaz M, Buabeid M, Kharaba ZJ, Yaseen HS, Murtaza G. Therapeutic effects and safe uses of plant-derived polyphenolic compounds in cardiovascular diseases: A review. Drug Des Devei Ther 2021; 15: 4713-4732.  
    7.Li YY, Feng J, Zhang XL, Cui YY. Pine bark extracts: Nutraceutical, pharmacological, and toxicological evaluation. J Pharmacol Exp Ther 2015; 353(1): 9-16.  
    8.Dziedziński M, Kobus-Cisowska J, Stachowiak B. Pinus species as prospective reserves of bioactive compounds with potential use in functional food—Current state of knowledge. Plants 2021; 10(7): 1306.  
    9.Iravani S, Zolfaghari B. Phytochemical analysis of Pinus eldarica bark. Res Pharm Sci 2014; 9(4): 243-250.  
    10.Babaee F, Safaeian L, Zolfaghari B, Javanmard SH. Cytoprotective effect of hydroalcoholic extract of Pinus eldarica bark against H2O2-induced oxidative stress in human endothelial cells. Iran Biomed J 2016; 20(3): 161-167.  
    11.Safaeian L, Zolfaghari B, Assarzadeh N, Ghadirkhomi A. Antioxidant and anti-hyperlipidemic effects of bark extract of Pinus eldarica in dexamethasone-induced dyslipidemic rats. J Adv Med Biomed Res 2019; 27(125): 49-56.  
    12.Huseini HF, Anvari MS, Rabbani S, Sharifi F, Arzaghi SM, Fakhrzadeh H. Anti-hyperlipidemic and anti-atherosclerotic effects of Pinus eldarica Medw. nut in hypercholesterolemic rabbits. DARU J Pharm Sci 2015; 23(1): 1-5.  
    13.Hajhashemi V, Zolfaghari B, Amin P. Anti-nociceptive and anti-inflammatory effects of hydroalcoholic extract and essential oil of Pinus eldarica in animal models. Avicenna J Phytomed 2021; 11(5): 494-504.  
    14.Sánchez-Rangel JC, Benavides J, Heredia JB, Cisneros-Zevallos L, Jacobo-Velázquez DA. The Folin-Ciocalteu assay revisited: Improvement of its specificity for total phenolic content determination. Anal Methods 2013; 5(21): 5990-5999.  
    15.Amin MM, El Gazayerly ON, Abd El-Gawad NA, Abd El-Halim SM, El-Awdan SA. Effect of formulation variables on design, in vitro evaluation of valsartan SNEDDS and estimation of its antioxidant effect in adrenaline-induced acute myocardial infarction in rats. Pharm Dev Technol 2016; 21(8): 909-920.  
    16.Saravanan G, Ponmurugan P, Sathiyavathi M, Vadivukkarasi S, Sengottuvelu S. Cardioprotective activity of Amaranthus viridis Linn: Effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats. Int J Cardiol 2013; 165(3): 494-498.  
    17.El-Marasy SA, El Awdan SA, Hassan A, Abdallah HM. Cardioprotective effect of thymol against adrenaline-induced myocardial injury in rats. Heliyon 2020; 6(7): e04431.  
    18.Safaeian L, Ghasemi-Dehkordi N, Javanmard SH, Namvar H. Antihypertensive and antioxidant effects of a hydroalcoholic extract obtained from aerial parts of Otostegia persica (Burm.) Boiss. Res Pharm Sci 2015; 10(3): 192-199.  
    19.Ribeiro D, Buttros J, Oshima C, Bergamaschi C, Campos R. Ascorbic acid prevents acute myocardial infarction induced by isoproterenol in rats: Role of nitric oxide synthase production. J Mol Histol 2009; 40(2): 99-105.  
    20.Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, et al. ST-segment elevation myocardial infarction. Nat Rev Dis Primers 2019; 5(1): 1-20.  
    21.Yeager JC, Iams SG. The hemodynamics of isoproterenol-induced cardiac failure in the rat. Circ Shock 1981; 8(2): 151-163.  
    22.Parveen K, Khan MR, Siddiqui WA. Pycnogenol® prevents potassium dichromate (K2Cr2O7)-induced oxidative damage and nephrotoxicity in rats. Chem-biol Interact 2009; 181(3): 343-350.  
    23.Enseleit F, Sudano I, Periat D, Winnik S, Wolfrum M, FlammerAJ, et al. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: A double-blind, randomized, placebo-controlled, cross-over study. Eur Heart J 2012; 33(13): 1589-1597.  
    24.Theadom A, Mahon S, Barker-Collo S, Winnik S, Wolfrum M, Flammer AJ, et al. Enzogenol for cognitive functioning in traumatic brain injury: A pilot placeb-controlled RCT. Eur J Neurol 2013; 20(8): 1135-1144.  
    25.Kim DS, Kim MS, Kang SW, Sung HY, Kang YH. Pine bark extract enzogenol attenuated tumor necrosis factor-α-induced endothelial cell adhesion and monocyte transmigration. J Agr Food Chem 2010; 58(11): 7088-7095.  
    26.Sudjarwo SA, Anwar C, Eraiko K, Wardani G. Cardioprotective activity of chitosan-Pinus merkusii extract nanoparticles against lead acetate induced cardiac cell damage in rat. Rasāyan J Chem 2019; 12(1): 184-191.  
    27.Rehman AU, Naz S, Zaman M, Saeed-ul-Hassan S, Iqbal J, Zaidi AA. A preliminary investigation of in vitro anti-thrombotic and anti-platelet activity of Pinus gerardiana. Biomed Res Ther 2017; 4(1): 1098-1109.  
    28.Kim SM, Kang SW, Jeon JS, Um BH. A comparison of Pycnogenol® and bark extracts from Pinus thunbergii and Pinus densiflora: Extractability, antioxidant activity and proanthocyanidin composition. J Med Plants Res 2012; 6(14): 2839-2849.  
    29.Aspé E, Fernández K. The effect of different extraction techniques on extraction yield, total phenolic, and anti-radical capacity of extracts from Pinus radiata bark. Ind Crops Prod 2011; 34(1): 838-844.  
    30.Afjeh MS. Determination of phenolic compounds in Pinus eldarica by HPLC. Planta Med 2013; 79(13): PJ55.  
    31.Seong EH, Gong DS, Shiwakoti S, Adhikari D, Kim HJ, Oak MH. Taxifolin as a major bioactive compound in the vasorelaxant effect of different pigmented rice bran extracts. Front Pharmacol 2022; 13: 799064.  
    32.Obeidat HM, Althunibat OY, Alfwuaires MA, Aladaileh SH, Algefare AI, Almuqati AF, et al. Cardioprotective effect of taxifolin against isoproterenol-induced cardiac injury through decreasing oxidative stress, inflammation, and cell death, and activating Nrf2/HO-1 in mice. Biomolecules 2022; 12(11): 1546.  
    33.Tang Z, Yang C, Zuo B, Zhang Y, Wu G, Wang Y, et al. Taxifolin protects rat against myocardial ischemia/reperfusion injury by modulating the mitochondrial apoptosis pathway. Peer J 2019; 7: e6383.  
    34.Mangels DR, Mohler III ER. Catechins as potential mediators of cardiovascular health. Arterioscler Thromb Vasc Biol 2017; 37(5): 757-763.  
    35.Torres-Fuentes C, Suarez M, Aragones G, Mulero M, Ávila-Román J, Arola-Arnal A, et al. Cardioprotective properties of phenolic compounds: A role for biological rhythms. Mol Nutr Food Res 2022; 66(21). doi: 10.1002/mnfr.202100990.  
    36.Yogeeta SK, Gnanapragasam A, Kumar SS, Subhashini R, Sathivel A, Devaki T. Synergistic interactions of ferulic acid with ascorbic acid: Its cardioprotective role during isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 2006; 283: 139-146.  
    

Publisher’s note The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
  [Table 1], [Table 2]